Chemical activators of Vmn2r14 include several neurotransmitters and signaling molecules that engage various receptors, initiating a cascade of intracellular events that activate the protein. Acetylcholine is one such activator; it interacts with nicotinic acetylcholine receptors, which are part of the cholinergic signaling pathway. This interaction stimulates a sequence of reactions that leads to the activation of Vmn2r14. Similarly, histamine, by binding to its respective receptors, initiates a signaling cascade that results in Vmn2r14 activation. Serotonin, another neurotransmitter, activates its receptors that can trigger pathways resulting in the activation of Vmn2r14. Dopamine also plays a role in this process through its interaction with dopamine receptors, which are coupled to G-proteins that facilitate the activation of Vmn2r14 as a part of their signaling mechanism.
In the same vein, glutamate and GABA operate through their respective receptors, both of which are pivotal in neurotransmission. Glutamate receptors, when activated, cause an influx of calcium ions that can lead to the activation of Vmn2r14. GABA, through its inhibitory action, also modulates signaling pathways that lead to Vmn2r14 activation. Norepinephrine and epinephrine both bind to adrenergic receptors, and their activation is known to influence downstream signaling pathways that include Vmn2r14. ATP, through its action on purinergic receptors, can activate signal transduction pathways that culminate in the activation of Vmn2r14. Nitric Oxide is another activator; it stimulates guanylate cyclase, which increases cyclic GMP levels and activates signaling pathways involving Vmn2r14. Furthermore, bradykinin and Substance P, by interacting with their respective receptors, engage signaling pathways that lead to the functional activation of Vmn2r14. These molecules play integral roles in the complex web of cellular signaling and highlight the multifaceted nature of Vmn2r14 regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine binds to histamine receptors which can trigger intracellular signaling cascades that activate Vmn2r14. | ||||||
Serotonin hydrochloride | 153-98-0 | sc-201146 sc-201146A | 100 mg 1 g | $118.00 $187.00 | 15 | |
Serotonin engages its receptors to initiate signal transduction processes activating Vmn2r14. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine binds to its receptors which are coupled to G-proteins, activating signaling pathways linked to Vmn2r14. | ||||||
L-Glutamic Acid | 56-86-0 | sc-394004 sc-394004A | 10 g 100 g | $297.00 $577.00 | ||
Glutamate interacts with its receptors, causing an influx of calcium ions that activate intracellular pathways involving Vmn2r14. | ||||||
GABA | 56-12-2 | sc-203053 sc-203053A sc-203053B sc-203053C | 10 g 25 g 5 kg 10 kg | $64.00 $136.00 $459.00 $765.00 | 2 | |
GABA binds to GABA receptors, which modulate signal transduction mechanisms that lead to the activation of Vmn2r14. | ||||||
L-Noradrenaline | 51-41-2 | sc-357366 sc-357366A | 1 g 5 g | $326.00 $485.00 | 3 | |
Norepinephrine activates adrenergic receptors influencing downstream signaling pathways that activate Vmn2r14. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to adrenergic receptors and activates signaling pathways that include Vmn2r14. | ||||||
ADP | 58-64-0 | sc-507362 | 5 g | $54.00 | ||
ATP binds to purinergic receptors, which through signal transduction pathways, can lead to the activation of Vmn2r14. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Bradykinin engages B2 receptors and activates signaling pathways connected to Vmn2r14. | ||||||
Substance P | 33507-63-0 | sc-201169 | 1 mg | $56.00 | ||
Substance P binds to neurokinin receptors, which activate related intracellular pathways resulting in Vmn2r14 activation. | ||||||